Target Name: INHBC
NCBI ID: G3626
Review Report on INHBC Target / Biomarker Content of Review Report on INHBC Target / Biomarker
INHBC
Other Name(s): activin beta-C chain | inhibin subunit beta C | Activin beta-C chain | IHBC | Inhibin beta C chain | Inhibin subunit beta C | INHBC_HUMAN | inhibin beta C subunit

INHBC Gene: Key Regulator of Heat Shock Response

INHBC (activin beta-C chain), also known as INHB (inhibitor of heat shock protein), is a protein that is expressed in various tissues and cells of the body. It plays a critical role in the regulation of cellular processes that are affected by heat stress, including cell division, apoptosis, and inflammation. INHBC is a key regulator of the heat shock response, which is a critical stress response that helps cells to survive and adapt to environmental changes.

The INHBC gene

The INHBC gene is located on chromosome 18 and encodes a protein that is composed of 215 amino acid residues. The protein has a molecular weight of 25.1 kDa and a calculated pI of 6.5. INHBC is predominantly expressed in the cytoplasm of cultured cells and is also found in the nucleus.

The INHBC protein

The INHBC protein is involved in the regulation of a variety of cellular processes that are affected by heat stress, including cell division, apoptosis, and inflammation. It is a key regulator of the heat shock response, which is a critical stress response that helps cells to survive and adapt to environmental changes. The INHBC protein is involved in the regulation of the following cellular processes:

1. Cell division: The INHBC protein is involved in the regulation of cell division by preventing the progressive elongation of the cell during the G1 phase of the cell cycle. It does this by interacting with the protein p21, which is a critical regulator of the cell cycle.
2. Apoptosis: The INHBC protein is involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death. It does this by interacting with the protein Bcl-2, which is a critical regulator of apoptosis.
3. Inflammation: The INHBC protein is involved in the regulation of inflammation, which is a critical response of the body to harmful stimuli. It does this by interacting with the protein NF-kappa-B, which is a critical regulator of inflammation.

The INHBC gene

The INHBC gene is located on chromosome 18 and encodes a protein that is composed of 215 amino acid residues. The protein has a molecular weight of 25.1 kDa and a calculated pI of 6.5. The INHBC gene is expressed in a variety of tissues and cells of the body, including the brain, heart, liver, and muscle.

The INHBC protein

The INHBC protein is a key regulator of the heat shock response, which is a critical stress response that helps cells to survive and adapt to environmental changes. The INHBC protein is involved in the regulation of the following cellular processes:

1. Cell division: The INHBC protein is involved in the regulation of cell division by preventing the progressive elongation of the cell during the G1 phase of the cell cycle. It does this by interacting with the protein p21, which is a critical regulator of the cell cycle.
2. Apoptosis: The INHBC protein is involved in the regulation of apoptosis, which is the process by which cells undergo programmed cell death. It does this by interacting with the protein Bcl-2, which is a critical regulator of apoptosis.
3. Inflammation: The INHBC protein is involved in the regulation of inflammation, which is a critical response of the body to harmful stimuli. It does this by interacting with the protein NF-kappa-B, which is a critical regulator of inflammation.

Drug targeting INHBC

Drug targeting INHBC is a promising strategy for the development of new treatments for a variety of diseases. By inhibiting the activity of the INHBC protein, drugs can

Protein Name: Inhibin Subunit Beta C

Functions: Inhibins and activins inhibit and activate, respectively, the secretion of follitropin by the pituitary gland. Inhibins/activins are involved in regulating a number of diverse functions such as hypothalamic and pituitary hormone secretion, gonadal hormone secretion, germ cell development and maturation, erythroid differentiation, insulin secretion, nerve cell survival, embryonic axial development or bone growth, depending on their subunit composition. Inhibins appear to oppose the functions of activins

The "INHBC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INHBC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

INHBE | INHCAP | Inhibitor of Apoptosis Proteins (IAPs) | Inhibitory kappaB Kinase (IKK) | INIP | INKA1 | INKA2 | INKA2-AS1 | INMT | INMT-MINDY4 | Innate Repair Receptor (IRR) | INO80 | INO80 complex | INO80B | INO80B-WBP1 | INO80C | INO80D | INO80E | Inositol 1,4,5-Trisphosphate Receptor (InsP3R) | Inositol hexakisphosphate kinase | Inositol Monophosphatase | INPP1 | INPP4A | INPP4B | INPP5A | INPP5B | INPP5D | INPP5E | INPP5F | INPP5J | INPP5K | INPPL1 | INS | INS-IGF2 | INSC | INSIG1 | INSIG2 | INSL3 | INSL4 | INSL5 | INSL6 | INSM1 | INSM2 | INSR | INSRR | Insulin-like growth factor | Insulin-like growth factor 2 mRNA binding protein | Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Insulin-like growth factor-binding protein | INSYN1 | INSYN2A | INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15